IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q1 2024 Holdings

Filed 2024-04-15 | 5 holdings | $449.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$225.6M19,963,15750.2%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$79.3M7,464,57217.6%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$67.9M2,869,56515.1%
Merus N VCOMN5749R100$52.6M1,169,02811.7%
Aura Biosciences Inc(AURA)COM05153U107$23.9M3,039,8925.3%